Radioimmunoassays for methotrexate, citrovorum factor, neocarzinostatin, and actinomycin D
Raso, V.
Cancer Treatment Reports 61(4): 585-590
1977
ISSN/ISBN: 0361-5960 PMID: 141980 Document Number: 114436
Antisera specific for methotrexate, citrovorum factor, actinomycin D, and neocarzinostatin have been elicited in rabbits by immunization with appropriate antigens. The antibodies have been used together with radiolabeled marker haptens to produce sensitive and specific radioimmunoassays for each of these drugs.
Document emailed within 1 workday
Related Documents
Mehta, B.M.; Hutchison, D.J. 1975: Assay for citrovorum factor (NSC-3590) in the presence of methotrexate (NSC-740) Cancer ChemoTherapy Reports 59(5): 935-937Baumgartner, G.; Heinz, R.; Linemayr, G. 1980: Methotrexate citrovorum factor therapy in advanced hypernephromas Wiener Klinische Wochenschrift 92(15): 526-530
Isacoff, W.H.; Morrison, P.F.; Aroesty, J.; Willis, K.L.; Block, J.B.; Lincoln, T.L. 1977: Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue Cancer Treatment Reports 61(9): 1665-1674
Abelson, H.T.; Ensminger, W.; Rosowsky, A.; Uren, J. 1978: Comparative effects of citrovorum factor and carboxypeptidase G1 on cerebrospinal fluid-methotrexate pharmacokinetics Cancer Treatment Reports 62(10): 1549-1552
Isacoff, W.H.; Eilber, F.; Tabbarah, H.; Klein, P.; Dollinger, M.; Lemkin, S.; Sheehy, P.; Cone, L.; Rosenbloom, B.; Sieger, L.; Block, J.B. 1978: Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue Cancer Treatment Reports 62(9): 1295-1304
Von Hoff, D.D.; Penta, J.S.; Helman, L.J.; Slavik, M. 1977: Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration Cancer Treatment Reports 61(4): 745-748
Tomita, K. 1986: Experimental studies on high-dose methotrexate with citrovorum factor chemotherapy for 89Sr-induced osteosarcoma murine model Japanese Journal of Antibiotics 39(5): 1219-1227
Tsurusawa, M.; Sasaki, K.; Matsuoka, H.; Katano, N.; Fujimoto, T. 1985: Studies on high-dose methotrexate with citrovorum factor rescue therapy in children: analysis of bone marrow cell kinetics by flow cytometry Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(9): 1827-1832
Lurain, J.R.; Chapman-Davis, E.; Hoekstra, A.V.; Schink, J.C. 2012: Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia Journal of Reproductive Medicine 57(7-8): 283-287
Cyriac, S.; Rajendranath, R.; Sridevi, V.; Sagar, T.G. 2011: Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy Journal of Reproductive Medicine 56(5-6): 219-223
Cagayan, M.S.F.S. 2012: High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy Journal of Reproductive Medicine 57(5-6): 231-236
Kikuchi, K.; Kusama, S.; Furue, H.; Muto, T.; Toriyama, K.; Wakiya, M. 1983: Clinical evaluation of neocarzinostatin in digestive system cancer. 2. Clinical studies on the administration of neocarzinostatin in advanced and recurrent carcinoma of the pancreas Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(8): 1872-1877
Kono, M.; Haneda, I.; Koyama, Y.; Kikuchi, M. 1974: Studies on the stability of antitumor protein, neocarzinostatin. I. Stability of solution of neocarzinostatin Japanese Journal of Antibiotics 27(6): 707-714
Sirotnak, F.M.; Moccio, D.M.; Dorick, D.M. 1977: Experimental chemotherapy with 5-arylpyrimidine antifolates: Further studies on toxicity and the responsiveness of ascitic, solid, and intracranial sarcoma 180 to DDMP and DDMP with citrovorum factor Cancer Treatment Reports 61(7): 1325-1332
Le Moigne, A.; Gabriel, A. 1971: Action of actinomycin D on cellular differentiation during the regeneration in planarians. 3. Ultrastructural study of tritiated actinomycin penetration into regenerating cells Zeitschrift für Zellforschung und mikroskopische Anatomie 122(1): 26-35
Huot, R.I.; Nardone, R.M.; Stromberg, K. 1987: Differential modulation of human chorionic gonadotropin production by methotrexate in normal and malignant placental cultures and its increase by dibutyryl cyclic adenosine monophosphate and/or actinomycin D in normal cultures Cancer Research 47(2): 383-387
Darabi, K.; Jaiswal, R.; Hostetler, S.; Bechtel, M.; Zirwas, M. 2009: Infectious complications in patients with psoriasis and rheumatoid arthritis treated with antitumor necrosis factor agents and methotrexate Journal of Drugs in Dermatology: Jdd 8(2): 175-178
Iqbal, M.P.; Malik, I.; Mehboobali, N. 1992: Appearance of a methotrexate binding plasma protein during high dose methotrexate therapy JPMA. Journal of the Pakistan Medical Association 42(8): 193-196
Cadman, E.C.; Glick, J.H.; Cross, J.; Horton, J.; Taylor, S.G. 1984: Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer Cancer Treatment Reports 68(6): 877-879
Antoni, C.; Kalden, J.R. 1999: Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 17(6 Suppl 18: S73-S77